Cytokinetics Inc (CYTK)
51.48
-0.34
(-0.66%)
USD |
NASDAQ |
Nov 04, 16:00
51.50
+0.02
(+0.04%)
After-Hours: 20:00
Cytokinetics Max Drawdown (5Y): 55.71% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 55.71% |
| September 30, 2024 | 55.71% |
| August 31, 2024 | 55.71% |
| July 31, 2024 | 55.71% |
| June 30, 2024 | 55.71% |
| May 31, 2024 | 55.71% |
| April 30, 2024 | 53.24% |
| March 31, 2024 | 53.24% |
| February 29, 2024 | 53.24% |
| January 31, 2024 | 53.24% |
| December 31, 2023 | 65.00% |
| November 30, 2023 | 65.00% |
| October 31, 2023 | 65.00% |
| September 30, 2023 | 65.24% |
| August 31, 2023 | 65.24% |
| July 31, 2023 | 65.24% |
| June 30, 2023 | 65.24% |
| May 31, 2023 | 65.24% |
| April 30, 2023 | 65.24% |
| March 31, 2023 | 65.24% |
| February 28, 2023 | 65.24% |
| January 31, 2023 | 65.24% |
| December 31, 2022 | 65.24% |
| November 30, 2022 | 65.24% |
| October 31, 2022 | 65.24% |
| Date | Value |
|---|---|
| September 30, 2022 | 65.24% |
| August 31, 2022 | 65.24% |
| July 31, 2022 | 65.24% |
| June 30, 2022 | 65.24% |
| May 31, 2022 | 65.24% |
| April 30, 2022 | 65.24% |
| March 31, 2022 | 65.24% |
| February 28, 2022 | 65.24% |
| January 31, 2022 | 65.24% |
| December 31, 2021 | 65.24% |
| November 30, 2021 | 65.24% |
| October 31, 2021 | 65.24% |
| September 30, 2021 | 65.24% |
| August 31, 2021 | 65.24% |
| July 31, 2021 | 65.24% |
| June 30, 2021 | 65.24% |
| May 31, 2021 | 65.24% |
| April 30, 2021 | 65.24% |
| March 31, 2021 | 65.24% |
| February 28, 2021 | 65.24% |
| January 31, 2021 | 65.24% |
| December 31, 2020 | 65.24% |
| November 30, 2020 | 65.24% |
| October 31, 2020 | 65.24% |
| September 30, 2020 | 65.24% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
53.24%
Minimum
Jan 2024
70.74%
Maximum
Nov 2019
63.75%
Average
65.24%
Median
May 2020
Max Drawdown (5Y) Benchmarks
| Alnylam Pharmaceuticals Inc | 42.46% |
| Biomarin Pharmaceutical Inc | 52.14% |
| Catalyst Pharmaceuticals Inc | 64.87% |
| Sarepta Therapeutics Inc | 64.93% |
| Ocugen Inc | 99.95% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 21.90 |
| Beta (5Y) | 0.7814 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 87.86% |
| Historical Sharpe Ratio (5Y) | 0.3641 |
| Historical Sortino (5Y) | 1.107 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.87% |